Items tagged with Drug-resistant TB

Price announced for new lifesaving TB drug pretomanid still too high (post with simple image)

Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.

Are pretomanid-containing regimens for TB a victory or a victory narrative? (post with simple image)

"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."

ATS, CDC, ERS and IDSA publish new clinical guideline for the treatment and prevention of drug-resistant TB (post with simple image)

New guideline emphasizes treatment of drug-resistant TB with all-oral regimens and provides recommendations for treatment of all contacts to multidrug-resistant TB patients.

TB Alliance responds to questions raised by activists in relation to pretomanid (post with simple image)

MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.

WHO announces changes to the treatment of drug-resistant TB (post with simple image)

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Page 89 of 89 · Total posts: 0

←First 88 89